MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment

Neuroreport
Basant K PuriDavid F Horrobin

Abstract

A 6-month randomized, placebo-controlled pilot study of the ethyl-ester of eicosapentaenoic acid (ethyl-EPA) was carried out in seven in-patients with advanced (stage III) Huntington's disease (three on ethyl-EPA, four on placebo; no significant difference in age or sex between the groups). After 6 months all the patients treated with ethyl-EPA improved on the orofacial component of the Unified Huntington's Disease Rating Scale while all the patients on placebo deteriorated on this scale (p < 0.03). Following subvoxel registration of follow-up 3D MRI brain scans with baseline scans, subtraction images showed that while the placebo was associated with progressive cerebral atrophy, the ethyl-EPA was associated with a reverse process. We conclude that treatment with ethyl-EPA is associated with beneficial motor and MRI changes.

Citations

Mar 12, 2003·Current Treatment Options in Neurology·Salil Manek, Mark F. Lew
Jan 18, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gregor E BergerPatrick D McGorry
Apr 13, 2004·International Clinical Psychopharmacology·Raphael M BonelliHans P Kapfhammer
Dec 10, 2003·CNS Drugs·Robin EmsleySusan J van Rensburg
Feb 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·László G PuskásTibor Farkas
Mar 11, 2008·Expert Review of Cardiovascular Therapy·Harold E BaysMichael H Davidson
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Raphael M Bonelli, Peter Hofmann
May 21, 2009·Expert Opinion on Emerging Drugs·Sarah L Mason, Roger A Barker
Nov 29, 2007·Expert Opinion on Investigational Drugs·Edward C Stack, Robert J Ferrante
Jan 24, 2016·Journal of Psychiatric Research·Binod Thapa ChhetryM Elizabeth Sublette
Dec 20, 2011·Parkinsonism & Related Disorders·T A Mestre, J J Ferreira
Jun 17, 2008·Progress in Neurobiology·Sabien van NeervenJörg Mey
Oct 15, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Charles S VenutoKarl Kieburtz
Dec 16, 2010·Journal of Cellular and Molecular Medicine·Dénes ZádoriLászló Vécsei
Mar 11, 2010·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Christoph U CorrellBarbara A Cornblatt
Oct 12, 2004·Nutrition·Undurti N Das, Krishna S Vaddadi
Mar 14, 2007·Brain Research Bulletin·Harald Murck, Mehar Manku
Jul 12, 2005·Epilepsy & Behavior : E&B·Alan W C YuenMatthias J Koepp
Jul 12, 2011·Neurobiology of Aging·Saskia N Sivananthan, Blair R Leavitt
Apr 23, 2004·Expert Opinion on Pharmacotherapy·Raphael M Bonelli, Peter Hofmann
Aug 9, 2005·Expert Opinion on Therapeutic Targets·Anthony J Hannan
Sep 24, 2004·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Paul F BostonCrispin N Bennett
Jun 26, 2012·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Gunter P EckertWalter E Muller
Jan 1, 2010·Journal of Nutrigenetics and Nutrigenomics·Basant K Puri, Mehar S Manku
Jul 21, 2006·The Cochrane Database of Systematic Reviews·C B JoyL A Joy
Jun 11, 2008·Neuromolecular Medicine·S C Dyall, A T Michael-Titus
Mar 1, 2018·Molecular Psychiatry·Hélèna L DenisFrancesca Cicchetti
Jun 17, 2006·International Review of Psychiatry·Krishna VaddadiJohn Waddington
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Tiago MestreCristina Sampaio
Aug 15, 2018·Journal of Huntington's Disease·Filipe B Rodrigues, Edward J Wild
Jun 17, 2006·International Review of Psychiatry·Gregor E BergerG Paul Amminger
Jul 8, 2020·Antioxidants·José Bono-YagüeRafael Pascual Vázquez-Manrique
May 6, 2003·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Marianne Haag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.